From Individuals to International Policy: Achievements and Ongoing Needs in Diabetes Advocacy

Current Diabetes Reports

Volumn 15, Issue 9, 2015, Pages

  Hilliard, Marisa E ^a   Oser, Sean M ^b   Close, Kelly L ^c   Liu, Nancy F ^c   Hood, Korey K ^d   Anderson, Barbara J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c diaTribe   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Advocacy; Policy; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ACCESS TO INFORMATION; ATTITUDE TO ILLNESS; AWARENESS; DIABETES EDUCATION; DIABETES MELLITUS; DOCTOR PATIENT RELATION; EMPOWERMENT; FUNDING; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; MEDICAL DECISION MAKING; PATIENT ADVOCACY; PATIENT INFORMATION; PROGRAM COST EFFECTIVENESS; PUBLIC-PRIVATE PARTNERSHIP; REVIEW; SELF CONCEPT; STIGMA; FOOD AND DRUG ADMINISTRATION; PUBLIC POLICY; UNITED STATES;

DIABETES MELLITUS; HUMANS; PUBLIC POLICY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84937918503     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-015-0636-z     Document Type: Review

References (76)

1. Glasgow RE, Wagner EH, Kaplan RM, Vinicor F, Smith L, Norman J. If diabetes is a public health problem, why not treat it as one? A population-based approach to chronic illness. Ann Behav Med. 1999;21:159–70.
2. Albright A. The public health approach to diabetes. Am J Nurs. 2007;107:39–42.
3. Centers for Disease Control and Prevention. National Diabetes Statistics report: Estimates of diabetes and its burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services. 2014.
4. Global status report on noncommunicable diseases 2014. Geneva, World Health Organization. 2012.
5. Valenzuela JM, Seid M, Waitzfelder B, … Mayer-Davis EJ on behalf of the SEARCH for Diabetes in Youth Study Group. Prevalence of and disparities in barriers to care experienced by youth with type 1 diabetes. J Pediatr. 2014;164:1369–1375.
6. Randall L, Begovic J, Hudson M, … Umpierrez G. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabet Care. 2011;34:1891–1896.
7. Smith-Spangler CM, Bhattacharya J, Goldhaber-Fiebert JD. Diabetes, its treatment, and catastrophic medical spending in 35 developing countries. Diabetes Care. 2012;35:319–26.
8. International Diabetes Federation. IDF diabetes atlas update poster. 6th ed. Brussels: International Diabetes Federation; 2014.
9. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033–46.
10. American Diabetes Association. Children and adolescents. Sec. 11. In Standards of Medical Care in Diabetes-2015. Diabetes Care. 2015;39(Suppl 1).
11. Hillson R. Embarrassing diabetes. Pract Diabet. 2014;31:313–4.
12. Vishwanath A. Negative public perceptions of juvenile diabetics: applying attribution theory to understand the public’s stigmatizing views. Health Commun. 2014;29:516–26.
13. Wolf A, Liu N. The numbers of shame and blame: how stigma affects patients and diabetes management. Diatribe 2014. Accessed from http://diatribe.org/issues/67/learning-curve on March 16 2015. This is an important study demonstrating the substantial stigma experienced by people with all types of diabetes, highlighting the critical need for advocacy.
14. Browne JL, Ventura A, Mosely K, Speight J. ‘I call it the blame and shame disease’: a qualitative study about perceptions of social stigma surround type 2 diabetes. BMJ Open. 2013;3:e003384.
15. Golden SH, Brown A, Cauley JA, … Anton B. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors—an endocrine society scientific statement. J Clin Endocrinol Metab. 2012;97:e1579–e1639.
16. Turvey J. Kids count in Congress. MLO-Online 2005. Accessed from http://www.mlo-online.com/articles/200508/0805washreport.pdf 17 Mar 2015.
17. Israel BA, Coombe CM, Cheezum RR, … Burris A. Community-based participatory approach: A capacity-building approach for policy advocacy aimed at eliminating health disparities. Am J Publ Health. 2010;100:2094–2102.
18. Izumi BT, Schulz AJ, Israel BA, … Sand SL. The one-pager: a practical policy advocacy tool for translating community-based participatory research into action. Prog Commun Health Partnersh. 2010;4:141–147. This is a useful and practical guide to use research for effective advocacy.
19. Wallerstein N. What is the evidence on effectiveness of empowerment to improve health? Health Evidence Network Report 2006; WHO Regional Office for Europe: Copenhagen.
20. Wiltshire J, Cronin K, Sarto GE, Brown R. Self-advocacy during the medical encounter: use of health information and racial/ethnic differences. Med Care. 2006;44:100–9.
21. Madrigal DS, Salvatore A, Casillas G, Casillas C, Vera I, Eskenazi B, et al. Health in my community: conducting and evaluating PhotoVoice as a tool to promote environmental health and leadership among Latino/a youth. Prog Commun Health Partnersh. 2014;8:317–29.
22. Monaghan M, Hilliard ME, Sweenie R, Riekert K. Transition readiness in adolescents and emerging adults with diabetes: the role of patient–provider communication. Curr Diabet Rep. 2013;13:900–8.
23. Sawicki GS, Lukens-Bull K, Yin X, … Wood D. Measuring the transition readiness of youth with special healthcare needs: validation of the TRAQ-transition readiness assessment questionnaire. J Pediatr Psychol. 2009;36:160–171.
24. Palmas W, Findley SE, Mejia M, … Carrasquillo O. Results of the Northern Manhattan community outreach project: a randomized trial studying a community health worker intervention to improve diabetes care in Hispanic adults. Diabet Care. 2014;37:963–969.
25. Grant C, Pan J. A comparison of five transition programmes for youth with chronic illness in Canada. Child Care Health Dev. 2011;37:815–20.
26. Necheles JW, Chung EQ, Hawes-Dawson J, … Schuster MA. The teen photovoice project: a pilot study to promote health through advocacy. Prog Commun Health Partnersh. 2007;1:221–229.
27. Wood FG, Payne-Foster P, Kelly R, Lewis DM. Learning and living diabetes: development of a college diabetes seminar course. Diabet Spectrum. 2011;24:42–6.
28. Greene MA. Diabetes legal advocacy comes of age. Diabet Spectrum. 2006;19:171–9.
29. Griffin JW. Employment rights of people with diabetes: changing technology and changing law. J Diabet Sci Technol. 2013;7:345–9.
30. Graff MR. AADE legislative advocacy: perspectives on prevention. Diabet Educ. 1997;23:241.
31. American Diabetes Association. Diabetes advocacy. Sec 14. In standards of medical care in diabetes—2015. Diabetes Care. 2015;38 Suppl 1:S86–7. This is the first time the American Diabetes Association has recognized the importance of advocacy in its Standards of Medical Care, highlighting the growing recognition of advocacy as an integral component of living with diabetes and reflecting the many achievements of national and international organizations to promote advocacy.
32. Siminerio JM, Dimmick B, Jackson CC, Deeb LC. The crucial role of health care providers in advocating for students with diabetes. Clin Diabet. 2012;30:34–7.
33. Wood JM. Protecting the rights of school children with diabetes. J Diabetes Sci Technol. 2013;7:339–44.
34. Author N. Towards the policy reforms we need to tackle NCDs—an interview with Badara Samb. Diabet Voice. 2011;56:17–9.
35. Pramod S. Non-governmental organizations (NGO’s) and diabetes: advocacy for support services in resource-poor nations. Endocr Abstr. 2012;29:P519.
36. Colaguiri R, Short R, Buckley A. The status of national diabetes programmes: a global survey of IDF member associations. Diabetes Res Clin Pract. 2010;87:137–42.
37. United Nations. Resolution adopted by the General Assembly on 20 December 2006. Accessed from http://daccess-ods.un.org/TMP/9047121.4056015.html 31 Mar 2015.
38. Siegel K, Venkat Narayan KM. The unite for diabetes campaign: overcoming constraints to find a global policy solution. Glob Health. 2008;4:3.
39. Mbanya JC. Calling the world to action on diabetes. Diabet Voice. 2011;56:15–6.
40. Schulz AJ, Israel BA, Zimmerman MA, Checkoway BN. Empowerment as a multi-level construct: perceived control at the individual, organizational, and community levels. Health Educ Res. 1995;10:309–27.
41. Galer-Unti RA, Tappe MK, Lachenmayr S. Advocacy 101: getting started in health education advocacy. Health Promot Pract. 2004;5:280–8. This resource provides practical strategies for health advocacy.
42. Siminerio LM, AlbaneseO’Neill A, Chiang JL, Hathaway K, Jackson CC, Weissberg-Benchell J, Wright JL, Yatvin AL, Deeb LC. Care of young children with diabetes in the child care setting: a position statement of the American Diabetes Association. 2014;37:2834–2842.
43. National Diabetes Education Program. Helping the student with diabetes succeed: a guide for school personnel. 2010. Accessed from http://www.ndep.nih.gov/media/NDEP61_SchoolGuide_4c_508.pdf 16 Mar 2015.
44. California Supreme Court Ruling Supports Access to Insulin for California Students. Accessed from http://www.diabetes.org/living-with-diabetes/parents-and-kids/diabetes-care-at-school/access-to-insulin-for-california-students-deprived.html 16 Mar 2015.
45. Nightscout. 2015. Accessed from http://www.nightscout.info/ 16 Mar 2015.
46. CGM in the Cloud Facebook group. Accessed from https://www.facebook.com/groups/cgminthecloud/ 16 Mar 2015.
47. Linebaugh K. Citizen hackers tinker with medical devices. Wall Street J. 2014. Accessed from http://www.wsj.com/articles/citizen-hackers-concoct-upgrades-for-medical-devices-1411762843 31 Mar 2015.
48. Riordan A. Open source and the cloud: changing the lives of people with type 1 diabetes. Microsoft News 2014. Accessed from http://news.microsoft.com/features/open-source-and-the-cloud-changing-the-lives-of-people-with-type-1-diabetes/ 31 Mar 2015.
49. Leibrand S. How and why we are working with the FDA. 2014. Accessed from http://diyps.org/2014/10/12/how-and-why-we-are-working-with-the-fda-background-and-a-brief-summary-of-the-recent-meeting-with-the-fda-about-the-nightscout-project/ 31 Mar 2015.
50. US Food and Drug Administration. FDA approval of Dexcom Share. 2015. Accessed from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm431385.htm 31 Mar 2015.
51. JDRF. Children’s Congress. Accessed from http://cc.jdrf.org/about-jdrf-childrens-congress/ 26 Mar 2015.
52. PLAID. Accessed from http://theplaidjournal.com/index.php/CoM/index 26 Mar 2015.
53. Gale EAM. Dying of diabetes. Lancet. 2006;368:1626–8.
54. Beran D, Yudkin JS, de Courten M. Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia. Diabetes Care. 2005;28:2136–40.
55. IDF. Life for a child. Accessed from http://www.idf.org/lifeforachild/the-programme 31 Mar 2015.
56. P4DC. Spare a rose. Accessed from http://www.p4dc.com/spare-a-rose/faq/ 31 Mar 2015.
57. Kern R. Blood glucose meter accuracy problems acknowledged by FDA, industry, and clinicians. The Gray Sheet. 2013. Accessed from https://www.pharmamedtechbi.com/publications/the-gray-sheet/%2039/21/blood-glucose-meter-accuracy-problems-acknowledged-by-fda-industry-and-clinicians 15 May 2015.
58. Strip Safely. About the StripSafely collaboration. Accessed from http://www.stripsafely.com/49-2/ 15 May 2015.
59. Strip Safely. 556, Thanks—congratulations DOC! Accessed from http://www.stripsafely.com/556-thanks-congratulations-doc/ 15 May 2015.
60. diaTribe. FDA hosts the first live patient chat on diabetes and glucose monitoring devices; how you can influence FDA guidelines. Accessed from http://diatribe.org/issues/63/new-now-next/4 15 May 2015.
61. FDA. FDA–patient dialogue on the unmet needs in diabetes. Accessed from http://www.fda.gov/downloads/ForPatients/Illness/Diabetes/UCM427478.pdf 15 May 2015.
62. Parker-Pope T. Diabetes: underrated, insidious and deadly. New York Times 2008. Accessed from http://www.nytimes.com/2008/07/01/health/01well.html 31 Mar 2015.
63. Institute of Medicine (US) Forum on Drug Discovery, Development and Translation. Transforming clinical research in the united state: challenges and opportunities: workshop summary. 2010. Accessed from http://www.ncbi.nlm.nih.gov/books/NBK50888/ 31 March 2015.
64. Manganiello M, Anderson M. Back to basics: HIV/AIDS advocacy as a model for catalyzing change. Accessed from http://hcmstrategists.com/wp-content/themes/hcmstrategists/docs/Back2Basics_HIV_AIDSAdvocacy.pdf 31 Mar 2015.
65. Bazell R. HER-2: the making of herceptin, a revolutionary treatment for breast cancer. 1998: Random House.
66. Collyar D. How have patient advocates in the United State benefited cancer research? Nat Rev Cancer. 2005;5:73–8.
67. Manganiello M. What has been accomplished by other patients (and how). Orlando: MasterLab; 2014.
68. Johnson JA, Edwards AL. Evidence and advocacy: are all things considered? Can Med Assoc J. 2006;174:1856–7.
69. Trickett EJ, Beehler S, Deutsch C, … Trimble JE. Advancing the science of community-level interventions. Am J Public Health. 2011;101:1410–1419.
70. Varkey P, Reller MK, Resar RK. Basics of quality improvement in health care. Mayo Clin Proc. 2007;82:735–9.
71. Arent S. The role of diabetes healthcare professionals in diabetes discrimination issues at work and school. Diabet Educ. 2002;28:1021–7.
72. Schwartz L. Is there an advocate in the house? The role of health care professionals in patient advocacy. J Med Ethics. 2002;28:37–40.
73. Lorber D, Gavlak G. Stopping diabetes through advocacy: the role of health care professionals. Clin Diabet. 2012;30:179–82. This important paper provides concrete examples of how healthcare professionals can and should become advocates for their patients and for the greater diabetes community.
74. Saxe JS. Promoting healthy lifestyles and decreasing childhood obesity: increasing physician effectiveness through advocacy. Ann Fam Med. 2011;9:546–8.
75. Ducat L, Philipson LH, Anderson BJ. The mental health comorbidities of diabetes. J Am Med Assoc. 2014;312:1–2.
76. Ducat L, Rubenstein A, Philipson LH, Anderson BJ. A review of the mental health issues of diabetes conference. Diabetes Care. 2015;38:333–8.